See the DrugPatentWatch profile for ozempic

Ozempic (generic name: semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to improve glycemic control in adults with type 2 diabetes, in addition to diet and exercise [1]. It is important to note that while using Ozempic, patients should follow their healthcare provider's guidance on diet, including sugar intake.

Regarding sugar substitutes, there is no specific list of sugar substitutes that patients should avoid while taking Ozempic. However, patients should be aware of their overall sugar intake and follow a balanced diet as recommended by their healthcare provider.

It is also important to note that Ozempic can cause gastrointestinal side effects such as nausea, vomiting, and diarrhea [1]. Consuming sugar substitutes or artificial sweeteners may exacerbate these symptoms in some individuals. Therefore, patients should monitor their tolerance to sugar substitutes and adjust their intake accordingly.

In summary, while there are no specific sugar substitutes to avoid when taking Ozempic, patients should be mindful of their overall sugar intake and follow their healthcare provider's dietary recommendations.

Sources:
[1] FDA. (2017). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. <https://www.fda.gov/media/108131/download>
[2] DrugPatentWatch.com. (n.d.). Ozempic (semaglutide) Drug Profile. <https://www.drugpatentwatch.com/drugs/ozempic>